Mohsin Khan, MD
Clinical Cardiac Electrophysiology · Grafton, WINPI 1184856312
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,542 of the $24,568 with a category attached, or 83.6%. 4 manufacturers reported payments, led by Medtronic at 43.2% of the total. Reporting peaked in 2020 at $10,524 and has fallen 99.9% since, to $13 in 2022.
Across 31 payments — averaging $792.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$9K
- Abbott$5K
- Medical Device Business Services, Inc.$291
What the payments were for
- Grants$20,54284%
- Travel & lodging$2,0418%
- Food & beverage$1,3566%
- Education$6293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $10,612 |
| Boston Scientific | 10 | $9,130 |
| Abbott | 14 | $4,535 |
| Medical Device Business Services, Inc. | 4 | $291 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,568 in reported general payments places this provider in the 75th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
See all clinical cardiac electrophysiology providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,002 | $1,035,204 |
| XareltoRivaroxaban | 221 | $258,854 |
| MultaqDronedarone Hcl | 20 | $21,495 |
| Flecainide Acetate | 375 | $16,661 |
| Dofetilide | 127 | $12,756 |
| Metoprolol Succinate | 836 | $9,842 |
| Mexiletine Hcl | 61 | $8,860 |
| Midodrine Hcl | 100 | $6,618 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 181 | $6,495 |
| Amiodarone Hcl | 401 | $6,327 |
| Propafenone Hcl | 45 | $3,392 |
| Pyridostigmine Bromide | 64 | $2,965 |
| Metoprolol Tartrate | 337 | $2,398 |
| SotalolSotalol Hcl | 93 | $1,560 |
| Warfarin Sodium | 102 | $1,398 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Grafton
- Imran NiaziMilwaukee$1M
- Miguel LealMadison$202K
- Jodi ZilinskiMilwaukee$173K
- Sanjay DeshpandeBeloit$133K
- Divya KorpuEau Claire$94K
- Marcie BergerMilwaukee$67K
- Mohammad MortadaMilwaukee$65K
- Andy KieuMilwaukee$62K
- Daniel NelsonAppleton$50K
- Hannah WeyMilwaukee$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.